Identification of Novel IGF1R Kinase Inhibitors by Molecular Modeling and High-Throughput Screening.
R Moriev, O Vasylchenko, M Platonov, O Grygorenko, K Volkova, S Zozulya
Index: Acta Naturae 5(2) , 90-9, (2013)
Full Text: HTML
Abstract
The aim of this study was to identify small molecule compounds that inhibit the kinase activity of the IGF1 receptor and represent novel chemical scaffolds, which can be potentially exploited to develop drug candidates that are superior to the existing experimental anti-IGF1R therapeuticals. To this end, targeted compound libraries were produced by virtual screening using molecular modeling and docking strategies, as well as the ligand-based pharmacophore model. High-throughput screening of the resulting compound sets in a biochemical kinase inhibition assay allowed us to identify several novel chemotypes that represent attractive starting points for the development of advanced IGF1R inhibitory compounds.
Related Compounds
Related Articles:
IGFBP-2 directly stimulates osteoblast differentiation.
2014-11-01
[J. Bone Miner Res. 29(11) , 2427-38, (2014)]
2006-04-01
[Mol. Cancer Ther. 5 , 1079-1086, (2006)]
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.
2016-03-01
[J. Pathol. 238 , 543-9, (2016)]
2016-01-01
[J. Chemother. 28 , 44-9, (2016)]
2015-11-01
[Lung Cancer 90 , 175-81, (2015)]